Perifera vasodilatatorer
Granskad av Dr Philippa Vincent, MRCGPSenast uppdaterad av Dr Surangi Mendis, MRCGPSenast uppdaterad 28 sept 2023
Uppfyller patientens redaktionella riktlinjer
- Ladda nerLadda ner
- Dela
- Language
- Diskussion
- Ljudversion
- Lägg till i föredragna källor på Google
Perifera vasodilatatorer är läkemedel som används för att behandla tillstånd som påverkar blodkärlen i kroppens yttre (perifera) delar, såsom armar och ben. Till exempel används de för att behandla perifer artärsjukdom och Raynauds fenomen. De lindrar symtomen på dessa tillstånd genom att vidga blodkärlen och förhindra att de blir smalare (kontraherar). Dessa läkemedel ordineras vanligtvis endast efter att egenvårdsåtgärder har prövats och symtomen inte förbättras.
Överblick
Peripheral vasodilators are medicines that widen blood vessels.
They are used to treat conditions like peripheral arterial disease and Raynaud's phenomenon.
Different types work in various ways, such as blocking chemicals or reducing blood thickness.
These medicines are only available on prescription, usually after self-help measures have been tried.
Side effects can vary depending on the specific drug.
If you notice yellowing of skin or eyes while taking naftidrofuryl or moxisylyte, see a doctor immediately.
What are peripheral vasodilators?
Peripheral vasodilators are used in peripheral arterial disease (PAD) and intermittent claudication to try to open up (dilate) the arteries; this helps to increase the distance you can walk before pain develops.
I Raynauds fenomen they are used to dilate the small blood vessels and prevent them from constricting. This helps to maintain the blood supply to the fingers, etc.
The peripheral vasodilator medications all reduce 'vascular resistance'. This is the resistance that should be overcome to push blood through the vessels in the limbs, to allow blood to flow.
There are a number of different peripheral vasodilator drugs. They include, nifedipine, cilostazol, moxisylyte, naftidrofuryl and pentoxifylline. These medicines are available as tablets and capsules and each one may have various other brand names (see Generic Medicines vs Brand Names).
Inositol nicotinate and pentoxifylline are not considered effective for PAD. Pentoxifylline and moxisylyte are not considered effective for Raynaud's phenomenon.
When are peripheral vasodilators usually prescribed?
In cases of intermittent claudication, a vasodilator is usually only prescribed if self-help measures such as exercise have not improved the symptoms and surgery is not being considered.
However, they do not work in all cases. Therefore, there is no point in continuing with these medicines if an improvement in symptoms is not seen within a few weeks. If symptoms do not improve, stopping treatment would usually be advised. If symptoms improve, the treatment can be continued. The treatment is usually reviewed regularly to ensure that it is still being of benefit.
In Raynaud's phenomenon, nifedipine is usually only prescribed after self-help measures (such as keeping the whole body warm, including the hands and feet, and stopping smoking) have been tried and the symptoms have not improved. Usually a short course of nifedipine is prescribed to begin with to see if it works..
How do peripheral vasodilators work?
Peripheral vasodilators work in slightly different ways to one another.
Cilostazol and inositol nicotinate work by widening the arteries that supply blood to the legs. Cilostazol also improves circulation by keeping platelets in the blood from sticking together and clotting.
Naftidrofuryl works by blocking the effects of a chemical called serotonin on the blood vessels. As a serotonin receptor blocker, Naftidrofuryl widens blood vessels to improve blood flow and also by allowing the body to make better use of oxygen available in the blood.
Nifedipin is a type of medicine called a calcium-channel blocker. It is sometimes used to treat high blood pressure but it is also a peripheral vasodilator. It works by widening the blood vessels and stopping them from going into a spasm or narrowing.
Moxisylyte is a type of medicine called an alpha-blocker. It works by relaxing the blood vessels, which in turn maintains the supply of blood to the fingers, toes, ears or nose.
Pentoxifylline works by decreasing the thickness of the blood. Blood is then able to flow more easily, especially in the small blood vessels of the hands and feet.
Which peripheral vasodilator is usually prescribed?
Peripheral arterial disease (PAD):
national guidelines only recommend the use of naftidrofuryl for people with intermittent claudication caused by PAD. Other peripheral vasodilators are not normally prescribed because there is little evidence that any of the others work very well for this condition. However, cilostazol can sometimes be used for the treatment of PAD in selected patients who do not respond to other treatments.
Raynaud's phenomenon:
Nifedipine is recommended to reduce the number and severity of 'vasospastic' attacks - when the blood vessels become narrow (constrict). Other peripheral vasodilators are not normally prescribed, as there is not much evidence to show that they work very well for Raynaud's phenomenon.
Sometimes, if the side-effects of nifedipine cannot be tolerated, a doctor may consider prescribing a different kalciumkanalblockerare såsom nicardipine, amlodipine eller felodipine. These medicines are not licensed to treat Raynaud's disease. Rarely, naftidrofuryl or inositol nicotinate may also be prescribed by some doctors to treat Raynaud's phenomenon.
How should peripheral vasodilators be taken?
How nifedipine is taken will depend upon the pattern of symptoms and how well symptoms improve with treatment.
All other vasodilators are taken every day.
What are the possible side-effects?
Most people who take peripheral vasodilators have no side-effects, or only minor ones. It is not possible in this leaflet to list all the possible side-effects of these medicines. For more detailed information, see the leaflet that comes within the medicine packet.
Nifedipin - some people develop flushing and huvudvärk. Serious side-effects are rare.
Naftidrofuryl - the most commonly reported side-effects are feeling sick, skin rash, stomach pains and runny stools (diarré). On rare occasions, some people taking naftidrofuryl have developed a liver disorder. If any yellowing of the skin or the whites of the eyes is seen, speak with a doctor straightaway.
Cilostazol - the most common side-effects include headache and diarrhoea. Less common side-effects include yrsel, weakness, feeling or being sick, matsmältningsbesvär, tummy (abdominal) pain, fast heartbeat, chest pain, runny nose, bruising, swollen ankles or feet, skin rash and itching.
Inositol nicotinate - side-effects are thought to be uncommon but may include flushing, dizziness, headache, feeling sick, being sick (vomiting), fainting and a rash.
Moxisylyte - the most common side-effects include mild illamående, diarrhoea, dizziness with a spinning sensation (yrsel), headache, facial flushing and a rash. On rare occasions, some people taking moxisylyte have developed a liver disorder. If any yellowing of the skin or the whites of the eyes is seen, speak with a doctor straightaway.
Pentoxifylline - the most common side-effects include nausea, vomiting, and dizziness which may occur. Uncommonly, some people experience a fast or irregular heartbeat.
Other considerations - nifedipine
Drinking grapefruit juice can interact with nifedipine and alter its effect. Therefore, grapefruit juice should be avoided by anyone taking this particular vasodilator.
Can I buy peripheral vasodilators?
No, you cannot buy oral peripheral vasodilators; you need a prescription to obtain these medicines.
Who cannot take peripheral vasodilators?
Most people are able to take a peripheral vasodilator; however, in some cases these medicines are best avoided.
Nifedipin - should not be given to people who:
Have severe damage to the heart muscle (cardiogenic shock).
Have a valve in the heart that does not open fully (advanced aortic stenosis).
Are within one month of having had a hjärtattack.
Have acute attacks of angina.
Naftidrofuryl - should not be given to people with a history of njurstenar.
Cilostazol - should not be given to people with:
Severe kidney or liver problems.
Uncontrolled högt blodtryck.
A magsår.
A history of having had surgery in the previous three months.
A history of having had a stroke in the previous six months.
Inositol nicotinate - should not be given to people who have had a recent heart attack (myocardial infarction) or stroke.
Moxisylyte - is safe to use in most people.
Pentoxifylline - should not be given to people who have had:
A stroke.
Extensive back of the eye (retinal) bleeding.
A heart attack.
Heart rhythm problems.
For more detailed information, see the leaflet that comes with the medicine packet.
Patientval för Heart and blood medicines

Behandling och medicinering
Nitratmedicin
Nitrate medicines include glyceryl trinitrate (GTN), isosorbide dinitrate and isosorbide mononitrate. Each has various brand names. Nitrate drugs do not alter the underlying cause of angina. (Angina is usually caused by narrowing of the heart arteries due to a build-up of a fatty substance called atheroma. See the separate leaflet called Angina.) However, nitrate medicines are good at easing and preventing angina pains.
av Dr Hayley Willacy, FRCGP

Behandling och medicinering
Aspirin och andra blodförtunnande läkemedel
Most people who have a cardiovascular disease (for example, angina, peripheral arterial disease, or a previous heart attack, transient ischaemic attack (TIA) or stroke) take a low-dose aspirin (75 mg) each day or clopidogrel (75 mg) each day. This reduces the risk of heart attack by about a third. It reduces the risk of having a stroke by about a quarter. A daily low dose of aspirin also reduces the risk of developing a number of common cancers, but it is not advised that everyone in the population should take aspirin for this reason. This is because in some people aspirin can increase the risk of stomach bleeding and stomach ulcers, which are sometimes fatal.
av Dr Toni Hazell, FRCGP
Vanliga frågor
Can I take peripheral vasodilators if I am pregnant or breastfeeding?
The provided information does not specify whether peripheral vasodilators are suitable for use during pregnancy or while breastfeeding. It is important to discuss your individual circumstances with your doctor or pharmacist.
How long will I need to take peripheral vasodilators for conditions like intermittent claudication or Raynaud's phenomenon?
For intermittent claudication, if an improvement in symptoms is seen, treatment can be continued. However, it is usually reviewed regularly to ensure continued benefit. For Raynaud's phenomenon, a short course of nifedipine might be prescribed initially to see if it works. The duration of treatment will depend on your response and the ongoing benefit experienced.
Are there any natural remedies or lifestyle changes that can act as peripheral vasodilators?
The article mentions that for intermittent claudication, self-help measures like exercise should be tried before medication. For Raynaud's phenomenon, keeping the whole body warm, especially hands and feet, and stopping smoking are mentioned as self-help measures. These are recommended before nifedipine is prescribed, suggesting they can help manage symptoms and improve blood flow, but the article does not mention specific 'natural remedies' that act as vasodilators.
What should I do if I accidentally take an extra dose of my peripheral vasodilator?
The article does not provide specific instructions for what to do in case of an accidental overdose. If this happens, it is important to seek medical advice.
Can peripheral vasodilators be used to treat erectile dysfunction?
The article focuses on the use of peripheral vasodilators for peripheral arterial disease and Raynaud's phenomenon. It does not mention their use for treating erectile dysfunction.
Vidare läsning och referenser
- Lower limb peripheral arterial disease; NICE Clinical Guideline (August 2012, updated December 2020)
- Aboyans V, Ricco JB, Bartelink MEL, et al; 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2017 Aug 26. doi: 10.1093/eurheartj/ehx095.
- Su KY, Sharma M, Kim HJ, et al; Vasodilators for primary Raynaud's phenomenon. Cochrane Database Syst Rev. 2021 May 17;5:CD006687. doi: 10.1002/14651858.CD006687.pub4.
- Raynauds fenomen; NICE CKS, november 2022 (endast tillgång i Storbritannien)
- Peripheral Arterial Disease; NICE CKS, mars 2024 (endast tillgängligt i Storbritannien)
- Golledge J, Drovandi A; Evidence-Based Recommendations for Medical Management of Peripheral Artery Disease. J Atheroscler Thromb. 2021 Jun 1;28(6):573-583. doi: 10.5551/jat.62778. Epub 2021 Mar 21.
Om recensentenVisa fullständig biografi

Dr Philippa Vincent, MRCGP
Allmänläkare, Medicinsk Författare
MB BS, Bsc, MRCGP (2000), DCH, DFSRH, DRCOG
Dr Philippa Vincent är en NHS-läkare som arbetar i norra London.
Artikelhistorik
Artikeln finns också på Engelska, Tyska, Spanska, Franska, Italienska, Portugisiska, Hindi, Hebreiska, Arabiska, och Svenska.
Nästa granskning: 26 sept 2028
28 sept 2023 | Senaste versionen
Delta i konversationen
Dela dina tankar eller erfarenheter med andra i vår patientgemenskaper.

Fråga, dela, anslut.
Bläddra i diskussioner, ställ frågor och dela erfarenheter inom hundratals hälsorelaterade ämnen.

Känner du dig sjuk?
Bedöm dina symtom online gratis
Anmäl dig till Patientens nyhetsbrev
Din veckovisa dos av tydliga, pålitliga hälsoråd - skrivna för att hjälpa dig känna dig informerad, självsäker och i kontroll.
Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.

